MARKET INTRODUCTION

Whole exome is a genomic technique for sequencing all of the protein-coding region of genes in a genome. Whole exome sequencing (WES) is available to patients who are searching for a unifying diagnosis for multiple medical conditions. Exome sequencing using exome enrichment can efficiently detect coding variants across a wide range of applications, including population genetics, genetic disease and cancer studies.

MARKET DYNAMICS
The whole exome sequencing market is anticipated to grow owning the driving factor such as, increasing applications in clinical diagnosis, high demand for the diagnosis of rare diseases, increasing demand for personalized medicine, awareness related to exome sequencing and increasing R&D in the field of genomics and others. On the other hand, the emerging economies offer lucrative opportunities for the whole exome sequencing market and the key players involved during the forecast period.

MARKET SCOPE
The "Global Whole Exome Sequencing Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of whole exome sequencing with detailed market segmentation by products & service, technology, applications and geography. The global whole exome sequencing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading the whole exome sequencing market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global whole exome sequencing market is segmented on the basis of products & service, technology and applications. Based on products and service, the market is segmented as systems, kits and services. On the basis of technology, the global whole exome sequencing market is segmented into sequencing by synthesis, ion semiconductor sequencing and other technologies. Based on the application the market is segmented into diagnostics, drug discovery and development, personalized medicine and others.

REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global whole exome sequencing market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The whole exome sequencing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting whole exome sequencing market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the whole exome sequencing market in these regions.

MARKET PLAYERS
The reports cover key developments in the whole exome sequencing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from whole exome sequencing market are anticipated to lucrative growth opportunities in the future with the rising demand for whole exome sequencing market in the global market. Below mentioned is the list of few companies engaged in the whole exome sequencing market.

The report also includes the profiles of key whole exome sequencing market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.


1. Thermo Fisher Scientific
2. Illumina, Inc
3. CENTOGENE AG
4. F. Hoffmann-La Roche Ltd
5. Macrogen Corp
6. Pacific Biosciences of California, Inc
7. GENEWIZ Inc
8. Bio-Rad Laboratories, Inc
9. Eurofins Scientifi
10. Stratos Genomics